Duchenne Muscular Dystrophy

An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy. - Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy. - Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies. - Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry. - Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle. - System Biology Approach: Gene Network Analysis for Muscular Dystrophy. - Proteomic Profiling of the Dystrophin-Deficient Brain. - Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models. - Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the
mdx
52 Mouse Model of Duchenne Muscular Dystrophy. - Designing Effective Antisense Oligonucleotides for Exon Skipping. - Identification of Splicing Factors Involved in
DMD
Exon Skipping Events Using an In Vitro RNA Binding Assay. - The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy. - PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment. - Proton Nuclear Magnetic Resonance (
¹
H NMR) Spectroscopy-Based Analysis of Lipid Components in Serum / Plasma of Patients with Duchenne Muscular Dystrophy (DMD). - Test of Anti-Fibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients. - Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy. - Advanced Methods to Study the Cross-Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells. - AAV6 Vector Production and Purification for Muscle Gene Therapy. - From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method.